The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation

Cytotherapy. 2022 Mar;24(3):223-224. doi: 10.1016/j.jcyt.2021.09.006. Epub 2021 Oct 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Survival
  • Cryopreservation*
  • Hematopoietic Stem Cells*